Association of ACE, VEGF and CCL2 gene polymorphisms with Henoch-Schönlein purpura and an evaluation of the possible interaction effects of these loci in HSP patients

Adv Clin Exp Med. 2017 Jul;26(4):661-664. doi: 10.17219/acem/62896.

Abstract

Background: Henoch-Schönlein purpura (HSP) is a multisystem, small vessel, leucocytoclastic vasculitis. It is predominantly a childhood vasculitis, rarely reported in adults. Studies have shown that several different genetic factors such as genes involved in inflammatory system and renin-angiotensin system (RAS) are important in the pathogenesis of Henoch-Schönlein purpura.

Objectives: The purpose of this study was to evaluate the independent effect of 3 gene polymorphisms including CCL2-2518 C/T, VEGF-634G/C and ACE(I/D) with HSP disease and their possible joint interactions in developing the disease.

Material and methods: In this case-control study 47 HSP cases and 74 unrelated healthy controls were enrolled for evaluation. All individuals were genotyped for CCL2-2518C/T, VEGF-634G/C and ACE(I/D) gene polymorphisms. The possible association of these polymorphisms with susceptibility to develop HSP disease independently and in different joint combinations was evaluated.

Results: The frequencies of TT genotype and T allele of CCL2-2518C/T gene polymorphism and CC genotype and C allele of VEGF-634G/C gene polymorphism were significantly high in HSP children (p-values = 0.005 and = 0.007 respectively). Interestingly, studying the joint interaction of these 2 genotypes (CC genotype of VEGF G-634C and TT genotype of CCL2 C-2518T) in this cohort showed a more significant effect in the development of the disease (p < 0.000, OR = 6.009). The frequency of TT genotype of CCL2 gene when combined with II genotype of ACE gene in HSP children was significantly higher (p < 0.000, OR = 4.213).

Conclusions: The results of this pilot study provide evidence of the possible gene-gene interaction effects of CCL2, VEGF and ACE genes in developing HSP disease.

Keywords: ACE; CCL2; Henoch–Schönlein purpura; VEGF; gene–gene interaction effect.

MeSH terms

  • Case-Control Studies
  • Chemokine CCL2 / genetics*
  • Child
  • Epistasis, Genetic*
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • IgA Vasculitis / genetics*
  • Male
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Single Nucleotide*
  • Vascular Endothelial Growth Factor A / genetics*

Substances

  • CCL2 protein, human
  • Chemokine CCL2
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Peptidyl-Dipeptidase A